TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History $8.69 -0.31 (-3.44%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$8.70 +0.01 (+0.13%) As of 07/11/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Stock Price Performance The TransCode Therapeutics (RNAZ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.97%, with a year-to-date return of -90.79%. In the past month, the stock has increased 20.69%, reflecting recent market activity. As of the latest close, TransCode Therapeutics traded at $8.69 with a market cap of $7.24 million and volume of 19,887 shares. Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.95%1 Month Performance+20.69%3 Month Performance-23.18%Year-To-Date Performance-90.79%1 Year Performance-99.97% RNAZ Stock Chart for Saturday, July, 12, 2025 RNAZ Chart by TradingView TransCode Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$9.00$8.69-3.44%$8.91$8.5019,887 shs$7.24 million07/10/2025$9.13$9.00-1.42%$9.34$8.7829,557 shs$7.47 million07/09/2025$9.25$9.13-1.30%$9.52$9.0027,741 shs$7.58 million07/08/2025$8.05$9.25+14.91%$9.70$8.0444,668 shs$7.71 million07/07/2025$8.04$8.05+0.12%$8.61$8.0513,003 shs$6.68 million07/04/2025$8.04$8.04$8.65$8.4213,376 shs$6.70 million07/03/2025$8.29$8.04-3.02%$8.65$8.4213,376 shs$6.67 million07/02/2025$7.50$8.29+10.53%$8.35$7.7423,133 shs$6.88 million07/01/2025$7.80$7.50-3.85%$7.99$7.4145,400 shs$6.23 million06/30/2025$7.97$7.80-2.13%$8.00$7.5012,038 shs$6.47 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$8.21$7.97-2.92%$8.40$7.8114,175 shs$6.62 million06/26/2025$7.66$8.21+7.18%$8.48$7.7035,700 shs$6.81 million06/25/2025$7.79$7.66-1.67%$7.95$7.527,830 shs$6.38 million06/24/2025$7.50$7.79+3.87%$8.45$7.3250,084 shs$6.47 million06/23/2025$7.57$7.50-0.92%$7.70$7.3610,696 shs$6.23 million06/20/2025$6.98$7.57+8.45%$7.92$6.8860,529 shs$6.31 million06/19/2025$6.98$6.98$7.08$6.8015,349 shs$5.79 million06/18/2025$6.82$6.98+2.35%$7.08$6.8015,349 shs$5.79 million06/17/2025$7.30$6.82-6.58%$7.20$6.8221,577 shs$5.68 million06/16/2025$6.97$7.30+4.73%$7.35$6.7530,754 shs$6.08 million06/13/2025$7.20$6.97-3.19%$7.62$6.8040,281 shs$5.81 million06/12/2025$7.56$7.20-4.76%$7.91$7.1837,496 shs$6.00 million06/11/2025$7.37$7.56+2.58%$7.69$7.4316,357 shs$6.30 million Related Companies Enlivex Therapeutics Stock Chart Coeptis Therapeutics Stock Chart Tempest Therapeutics Stock Chart NeuroSense Therapeutics Stock Chart Cadrenal Therapeutics Stock Chart Cognition Therapeutics Stock Chart ALX Oncology Stock Chart Cara Therapeutics Stock Chart Tenax Therapeutics Stock Chart Ovid Therapeutics Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
